Aqueous extract of Hibiscus sabdariffa inhibits pedestal induction by enteropathogenic E. coli and promotes bacterial filamentation in vitro

PLoS One. 2019 Mar 8;14(3):e0213580. doi: 10.1371/journal.pone.0213580. eCollection 2019.

Abstract

Diarrheic diseases account for the annual death of approximately 1.9 million children under the age of 5 years, and it is a major cause of work absenteeism in developed countries. As diarrheagenic bacteria, enteropathogenic Escherichia coli (EPEC) attach to cells in the small intestine, causing local disappearance of microvilli and inducing the formation of actin-rich pedestals that disrupt the intestinal barrier and help EPEC adhere to and infect intestinal cells. Antibiotics and other bioactive compounds can often be found by analyzing traditional medicines. Here a crude aqueous extract of Hibiscus sabdariffa, which typically grows in subtropical and tropical areas and is a popular medicinal tisane in many countries, was analyzed for antibacterial activity against EPEC. In standard microdilution assays, the extract showed a minimum inhibitory concentration of 6.5 mg/ml against EPEC growth. Time-kill kinetics assays demonstrated significant 24 h bactericidal activity at 25 mg/ml. The extract is able to impede pedestal induction. Not only did the extract inhibit preformed pedestals but it prevented pedestal induction as well. Remarkably, it also promoted the formation of EPEC filaments, as observed with other antibiotics. Our results in vitro support the potential of Hibiscus sabdariffa as an antimicrobial agent against EPEC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Enterotoxigenic Escherichia coli / growth & development*
  • Enterotoxigenic Escherichia coli / ultrastructure*
  • Hibiscus / chemistry*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Plant Extracts

Grants and funding

This work was funded by grants to NM-Q Instituto de Salud Carlos III FIS PS09/0080 confounded by European Social Funds (FSE), Banco Santander-Universidad Complutense intramural grant for 970629 validated group, crowdfunding project precipita.es (FECYT) and by a Ministerio de Economía, y Empresa (SAF2017-82967-R) to NM-Q. RM-S was supported by a FPI- MINECO fellowship (BES-2008-009174), EN-P and BC-V were supported by a UCM predoctoral fellowship and a MEC-FPU Fellowship (AP2010-0818), respectively.